Koyfin Home > Directory > Health Care > Amag Pharmaceuticals > EV / EBITDA (ltm)

Amag Pharmaceuticals EV / EBITDA (ltm) Chart (AMAG)

Amag Pharmaceuticals annual/quarterly EV / EBITDA (ltm) from 2015 to 2019. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the last twelve months (LTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
  • Amag Pharmaceuticals EV / EBITDA (ltm) for the quarter ending August 08, 2019 was 10.37 a 10.58% increase of 1.10 year over year
  • Amag Pharmaceuticals EV / EBITDA (ltm) for the last 12 months ending August 08, 2019 was 10.37 a 10.58% increase of 1.10 year over year
  • Amag Pharmaceuticals Annual EV / EBITDA (ltm) for 2019 was 10.37 a 8.26% increase of 0.86 from 2018
  • Amag Pharmaceuticals Annual EV / EBITDA (ltm) for 2019 was 9.51 a 1.43% increase of 0.14 from 2018
  • Amag Pharmaceuticals Annual EV / EBITDA (ltm) for 2019 was 9.38 a 1.11% increase of 0.10 from 2018
Other Valuation Metrics:
  • Amag Pharmaceuticals Market Cap for the quarter ending March 03, 2018 was $687m a 6.12% increase of 42m year over year
  • Amag Pharmaceuticals Price / Book for the quarter ending March 03, 2018 was 0.87 a 21.08% increase of 0.18 year over year
  • Amag Pharmaceuticals Enterprise Value for the quarter ending March 03, 2018 was $1,093m a 1.93% increase of 21m year over year
View Chart On Koyfin

Quarterly AMAG EV / EBITDA (ltm) Data

08/201910.37
08/20199.51
08/20199.38
08/20199.27
07/20198.84
07/20199.09
07/20199.08
07/20199.11
07/20199.02
07/20199.30

Annual AMAG EV / EBITDA (ltm) Data

201910.37
20199.51
20199.38
20199.27
20198.84
20199.09
20199.08
20199.11
20199.02
20199.30